Search Results - "pharmacodynamics"

A Double‐Blind, Phase I, Single Ascending Dose Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of BOS161721 in Healthy Subjects by Azra Hussaini, Rajat Mukherjee, Dina M. Berdieva, Christen Glogowski, Richard Mountfield, Peter T.C. Ho

Connect to this object online.

Reduction in C-Peptide Levels and Influence on Pharmacokinetics and Pharmacodynamics of Insulin Preparations: How to Conduct a High-Quality Euglycemic Clamp Study by Yi Tao, Mingxue Zhu, Junliang Pu, Peilin Zhang, Lei Wan, Chengyong Tang

Connect to this object online.

Population Pharmacokinetic and Pharmacodynamic Analysis of Dalbavancin for Long-Term Treatment of Subacute and/or Chronic Infectious Diseases: The Major Role of Therapeutic Drug Monitoring by Pier Giorgio Cojutti, Sara Tedeschi, Milo Gatti, Eleonora Zamparini, Marianna Meschiari, Paola Della Siega, Maria Mazzitelli, Laura Soavi, Raffaella Binazzi, Elke Maria Erne, Marco Rizzi, Anna Maria Cattelan, Carlo Tascini, Cristina Mussini, Pierluigi Viale, Federico Pea

Connect to this object online.

Pharmacokinetics and Pharmacodynamics of Esomezol DR, a New Dual Delayed-Release Formulation of Esomeprazole 20 Mg or 40 Mg, in Healthy Subjects by Kim HC, Yang E, Ban MS, Kim YK, Hong SH, Jung J, Jang IJ, Lee S

Connect to this object online.

Safety, pharmacokinetics, and pharmacodynamics of sofnobrutinib, a novel non‐covalent BTK inhibitor, in healthy subjects: First‐in‐human phase I study by Kyoko Miyamoto, Robert M. Miller, Christine Voors‐Pette, Jart A. F. Oosterhaven, Marieke van denDobbelsteen, Katsuhiro Mihara, Marian Geldof, Yuji Sato, Naomi Matsuda, Shirou Kirita, Masaaki Sawa, Akinori Arimura

Connect to this object online.

Assessment of ibrutinib scheduling on leukocyte, lymph node size and blood pressure dynamics in chronic lymphocytic leukemia through pharmacokinetic‐pharmacodynamic models by Eman I. K. Ibrahim, Mats O. Karlsson, Lena E. Friberg

Connect to this object online.

A randomized, double‐blind, comparative study of the pharmacodynamics and pharmacokinetics of GP40141 (romiplostim biosimilar) and reference romiplostim in healthy male volunteers by Igor Makarenko, Artem Dorotenko, Sergey Noskov, Veniamin Banko, Valeria Saparova, Alexandr Khokhlov, Evgeniia Zoreeva, Andrey Nedorubov, Bella Zinnatulina, Maria Gefen, Roman Drai

Connect to this object online.

Determination of Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Parameters of Doxycycline against <i>Edwardsiella ictaluri</i> in Yellow Catfish (<i>Pelteobagrus fulvidraco</i>) by Ning Xu, Miao Li, Xiaohui Ai, Zhoumeng Lin

Connect to this object online.

The safety, pharmacodynamics, and pharmacokinetics of immediate-release formulation containing esomeprazole 20 mg/sodium bicarbonate 800 mg in healthy adult male by Kim D, Park MS, Yoo BW, Hong T, Park SJ, Kim CO

Connect to this object online.

The dose regimen formulation of doxycycline hydrochloride and florfenicol injection based on ex vivo pharmacokinetic-pharmacodynamic modeling against the Actinobacillus pleuropneumoniae in pigs by Yuanyuan Yuan, Boyu An, Shuyu Xie, Wei Qu, Haihong Hao, Lingli Huang, Wanhe Luo, Jixiang Liang, Dapeng Peng

Connect to this object online.

Evaluation of pharmacokinetic, pharmacodynamic, efficacy, and safety data of low-dose ticagrelor versus standard dose in East Asians: a systematic review by Lee YJ, Kim HW, Choi JY, Lee BH, Lee SY

Connect to this object online.

The Emerging Discipline of Quantitative Systems Pharmacology by Tarek A. Leil

Subjects: “…Pharmacodynamics…”
DOAB: download the publication
DOAB: description of the publication

Model-Informed Precision Dosing

Subjects: “…pharmacodynamics…”
DOAB: download the publication
DOAB: description of the publication

Pharmacokinetics, pharmacodynamics, and safety of izuforant, an H4R inhibitor, in healthy subjects: A phase I single and multiple ascending dose study by Byung Hak Jin, Taegon Hong, Byung Won Yoo, Choon Ok Kim, Dasohm Kim, Youn Nam Kim, Min Soo Park

Connect to this object online.

A pharmacokinetics-pharmacodynamics study of single-dose total glucosides of paeony capsule on reducing serum total bile acid in hepatic injury rats by Ninghua Jiang, Bohong Zheng, Yihan Feng, Lei Yin, Yuanrong Liu, Lujing Cao, Ning Zheng, Suxiang Wu, Baoyue Ding, Xuan Huang, Jeffrey Wang, Shuyu Zhan

Connect to this object online.

Safety, tolerability, pharmacokinetics, and pharmacodynamics of HBM9161, a novel FcRn inhibitor, in a phase I study for healthy Chinese volunteers by Desmond Y. H. Yap, Jojo Hai, Paul C. H. Lee, Xueying Zhou, Michael Lee, Yu Zhang, Meng Wang, Xiaoxiang Chen

Connect to this object online.

Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Piperacillin-Tazobactam or Meropenem and Microbiological Outcome among Urologic Patients with Documented Gram-Negative Infections by Pasquale Maria Berrino, Milo Gatti, Matteo Rinaldi, Eugenio Brunocilla, Pierluigi Viale, Federico Pea

Connect to this object online.

Pharmacokinetics and Pharmacodynamics of Florfenicol in Plasma and Synovial Fluid of Pigs at a Dose of 30 mg/kg_bw Following Intramuscular Administration by Zoltán Somogyi, Patrik Mag, Réka Simon, Ádám Kerek, Pál Szabó, Ervin Albert, Imre Biksi, Ákos Jerzsele

Connect to this object online.

Integrating network pharmacology analysis and pharmacodynamic evaluation for exploring the active components and molecular mechanism of moutan seed coat extract to improve cognitive impairment by Yue Wang, Xinyan Wu, Kailin Yang, Qing Liu, Baoping Jiang, Runmei Yang, Peigen Xiao, Chunnian He

Connect to this object online.

Safety, pharmacokinetics, and pharmacodynamics of ART‐648, a PDE4 inhibitor in healthy subjects: A randomized, placebo‐controlled phase I study by Akira Tanaka, Hiroshi Nagabukuro, Kanako Kuniyeda, Haruhi Ando, Toshinori Higashi, Hirokazu Wakuda, Naoyuki Otani, Hideo Kudo, Masae Kuranari, Hidetoshi Furuie, Naoto Uemura

Connect to this object online.